Dilated Cardiomyopathy

Dilated cardiomyopathy is estimated to affect about 1 in 2,500 people, making it the third most common cause of heart failure and the leading indication for heart transplantation. See Introduction to Diseases of the Myocardium for how DCM fits into the broader phenotype framework this page builds on.

Definition

DCM is defined by LV dilation with global or regional systolic dysfunction not solely explained by abnormal loading conditions (hypertension, valvular disease) or coronary artery disease.

Systolic dysfunction is defined by an LVEF under 50% — a genuinely important threshold to state precisely, since lower cutoffs are sometimes quoted informally. Dilation is defined relative to population norms corrected for body size, sex, and age — in adults, this translates to specific, sex-different values:

Measurement	Men	Women
LV end-diastolic diameter	> 58 mm	> 52 mm
LV end-diastolic volume index	≥ 75 mL/m²	≥ 62 mL/m²

An older, still-encountered convention expresses dilation as a percentage of the predicted diameter for age and body surface area, rather than an absolute measurement: over 112% of predicted is the standard cutoff, with a more conservative 117% specifically proposed for family screening studies, where greater specificity matters more than sensitivity. These two conventions — absolute, sex-specific measurements versus percentage-of-predicted — aren’t directly interchangeable, and it’s worth knowing which one a given report or reference is using.

A Different, Lower Bar for Relatives

A relative of a patient with DCM is evaluated against a genuinely different standard than the index case. Isolated LV dilation with preserved systolic function, or the presence of the family’s known causative genetic variant, is sufficient for a diagnosis of DCM in a relative — reflecting the much higher prior probability that comes with a confirmed family history. In the absence of conclusive genetic information, DCM is considered familial when either one or more first- or second-degree relatives also have DCM, or an otherwise unexplained sudden cardiac death has occurred in a first-degree relative at any age with an established DCM diagnosis.

Etiology

20–35% of DCM is familial, inherited predominantly in an autosomal dominant pattern (less commonly X-linked, autosomal recessive, or mitochondrial), with more than 20 implicated loci and genes showing incomplete, age-dependent penetrance — the same genetic logic described for HCM on the Introduction to Diseases of the Myocardium page. Implicated genes encode sarcomeric proteins (overlapping with HCM genes), cytoskeletal and sarcolemmal proteins, nuclear envelope proteins (lamin A/C, or LMNA), and transcriptional coactivator proteins. LMNA-related DCM carries a specifically elevated stroke risk (8–22%) and a higher arrhythmic risk than other genetic subtypes, independent of the degree of systolic dysfunction — a genuine reason genotype can change management even once the phenotype looks the same as any other DCM.

Sporadic (non-familial) causes span infectious, toxic, autoimmune, endocrine, and nutritional categories:

Category	Examples
Infectious	Viral myocarditis (enteroviruses, adenoviruses, echoviruses, herpesviruses, parvovirus B19, HIV, SARS-CoV-2); bacterial (Lyme disease); mycobacterial; fungal; Chagas disease (parasitic); Kawasaki disease
Toxic	Alcohol, cocaine, amphetamines, chemotherapeutic agents (doxorubicin, trastuzumab), cobalt, anabolic/androgenic steroids
Autoimmune/inflammatory	Sarcoidosis, systemic lupus erythematosus, rheumatoid arthritis
Endocrine/metabolic	Hypo- or hyperthyroidism, pheochromocytoma, diabetes mellitus
Nutritional	Thiamine (beriberi), selenium, and carnitine deficiency
Neuromuscular	Duchenne, Becker, and Emery-Dreifuss muscular dystrophies
Other	Peripartum (last trimester through 5 months postpartum); tachycardia-induced; idiopathic (no identifiable cause after thorough evaluation)

Echocardiography’s Real Job: Confirm Dysfunction, Rule Out Mimics, Rarely Name the Cause

Echocardiography only rarely establishes the specific etiology of DCM — most echo appearances across this wide range of causes are genuinely nonspecific, even though the study is indispensable for confirming dysfunction, guiding management, and providing prognostic information. In a patient presenting with heart failure, echocardiography’s first job is distinguishing DCM from other causes of the same clinical picture: valvular heart disease, restrictive cardiomyopathy, and constrictive pericarditis all need to be actively excluded, not assumed absent.

A Structured Way to Think Through the Heart Failure Differential

Four features — LV chamber size, wall thickness, systolic function pattern (global vs. regional), and RV function — sort most heart failure presentations efficiently:

• Enlarged LV with reduced systolic function, globally → dilated cardiomyopathy
• Enlarged LV with reduced systolic function, regionally → more suggestive of ischemic disease than primary DCM
• Increased wall thickness, asymmetric → hypertrophic cardiomyopathy
• Increased wall thickness, concentric → more typical of hypertensive heart disease
• Normal LV size and function → diastolic dysfunction or HFpEF likely, once pericardial disease, valve disease, and noncardiac causes have been evaluated for and excluded
• Reduced RV systolic function, with normal pulmonary artery pressure → primary RV disease (RV infarction, ARVC)
• Reduced RV systolic function, with elevated pulmonary artery pressure → primary pulmonary hypertension or lung disease if no left heart disease is present; secondary pulmonary hypertension if left heart disease is present

A Few Echo Findings Do Point Toward a Specific Cause

Worth actively screening for, since they’re genuine exceptions to the “nonspecific” rule above:

• Regional wall motion abnormality following a coronary distribution → ischemic etiology, not primary DCM
• Prominent LV trabeculation → coexisting hypertrabeculation (see the Introduction to Diseases of the Myocardium page for how this phenotypic trait relates to, but isn’t itself classified as, a cardiomyopathy)
• A distinctive, abnormal myocardial texture → hemochromatosis
• Endomyocardial hyperechogenicity → hypereosinophilic syndrome
• Pericardial effusion → myocarditis as a contributing or underlying process
• Biventricular apical aneurysms with typical inferior wall akinesis → Chagas cardiomyopathy specifically, seen in roughly half of patients; apical thrombus is common, and global hypokinesis is a feature of advanced disease rather than the typical early presentation — meaning Chagas can genuinely look regional, mimicking ischemic disease, before it becomes diffusely global
• Severe systolic dysfunction with little or no ventricular dilation → raises fulminant myocarditis specifically, a genuine exception to dilation being a prerequisite for severe DCM-pattern dysfunction
• Apical ballooning with dyskinesis and relatively preserved basal contraction → the distinctive pattern of Takotsubo syndrome, which current guidance explicitly does not classify as a cardiomyopathy, given its usually transient course (see the Introduction page for the full reasoning), but which belongs in this differential because its echo appearance can otherwise be mistaken for an acute cardiomyopathy

LV Systolic Function

The echocardiographic appearance of DCM is fairly uniform across its many causes: a dilated LV with increased end-diastolic and end-systolic dimensions, impaired global contractility, and reduced systolic function. As the disease progresses, the ventricle becomes measurably more spherical — captured by the sphericity index (the ratio of transverse to long-axis LV diameter), which increases from its normal, more elongated value as the ventricle remodels.

• 2D biplane modified Simpson’s rule is the recommended method for calculating ejection fraction. Its main limitations are poor endocardial definition in up to 15% of patients (where contrast is recommended) and operator-dependent variability.
• The Teichholz method is specifically not recommended for EF calculation in DCM — its geometric assumptions, reasonable for a normally-shaped ventricle, produce meaningful inaccuracy once the ventricle has dilated and become more spherical.
• 3D echocardiography avoids geometric assumptions entirely and is especially valuable in DCM patients with large, abnormally-shaped ventricles, since it also avoids apical foreshortening.
• dP/dt (rate of pressure rise, from the mitral regurgitant CW signal) is used alongside EF as an additional marker of systolic dysfunction, rather than as a standalone measure — a slow rate of rise indicates reduced LV dP/dt in early systole.
• Stroke volume provides complementary hemodynamic information, useful for both management and prognosis; compensatory LV dilation often preserves a normal resting stroke volume even as ejection fraction falls.
• Global longitudinal strain by speckle tracking detects subclinical myocardial dysfunction before EF itself declines, and reduced GLS (a smaller-magnitude, less-negative value than the normal range) is an independently recognized marker of adverse prognosis. See LV Systolic Function for the general strain methodology this builds on.

M-Mode Signs

• Increased mitral E-point to septal separation (EPSS) — classically associated with EF under 30% when substantially elevated, though it’s worth understanding the actual mechanism: EPSS increases from the combination of LV dilation and reduced mitral leaflet excursion caused by low transmitral flow, not from dilation alone.
• The “B-bump” (or “AC-shoulder”) — a delayed, notched pattern of mitral valve closure on M-mode — correlates specifically with an elevated LV end-diastolic pressure, making it a genuinely useful adjunct to Doppler-based filling pressure estimates rather than a redundant finding.
• Reduced anteroposterior aortic root motion, reflecting reduced left atrial filling and emptying, and early aortic valve closure reflecting the same reduced stroke volume seen on Doppler below.

RV Function

RV size and function should be assessed in every DCM study, not reserved for cases with overt right heart failure — see Evaluation of the Right Ventricle for the complete approach. TAPSE and fractional area change are both commonly reduced, and RV dysfunction carries independent prognostic weight alongside LV ejection fraction.

Diastolic Function

Diastolic dysfunction typically accompanies the systolic impairment of DCM, and noninvasive filling pressure estimates are genuinely useful for clinical management. See LV Diastolic Function for the general framework; in DCM specifically, the expected pattern reflects reduced compliance from an LV operating on a steeper, less compliant segment of its pressure-volume curve once systolic dysfunction is present:

• A high E velocity, rapid deceleration slope, low A velocity, and E/A ratio above 1 is the expected pattern of reduced compliance — in effect, a restrictive-appearing or pseudonormalized pattern.
• When filling pressures are genuinely elevated, E/e′ rises to 15 or higher, and pulmonary vein a-wave velocity and duration both increase.
• This restrictive or pseudonormalized filling pattern, specifically when E/e′ exceeds 15, is itself a marker of poor prognosis — worth stating in a report as a prognostic finding, not just a diastolic function grade.
• Patterns of diastolic dysfunction in DCM can be genuinely complex and vary with volume status, medical therapy, and disease phase — a single snapshot shouldn’t be over-interpreted without clinical context.

Associated Findings

Secondary Mitral and Tricuspid Regurgitation

Secondary MR arises from a three-part mechanism: papillary muscle displacement from LV remodeling, the systolic dysfunction itself, and mitral annular dilation — tethering normal leaflets so they can no longer coapt completely. The resulting jet is often central, from symmetric tethering, rather than reliably eccentric the way primary valve pathology tends to produce — worth keeping in mind when jet direction is used to infer mechanism. See Mitral Regurgitation for the general severity-grading approach, which still applies once the secondary mechanism is confirmed. Tricuspid regurgitation develops through the analogous mechanism on the right side, from RV remodeling and tricuspid annular dilation.

LV Thrombus

A careful search for apical LV thrombus is indicated when LVEF falls below 35% — though with current medical therapy, actual prevalence is low, a reassuring shift from older literature. Apical four-chamber and two-chamber views are the key windows, and contrast echocardiography should be used when visualization is suboptimal, since missing a thrombus has direct anticoagulation and embolic-risk implications.

Pulmonary Hypertension

Develops in many DCM patients from chronically elevated left atrial pressure transmitted backward through the pulmonary circulation, estimated from the tricuspid regurgitant jet velocity in the standard way.

LV Dyssynchrony and CRT Candidacy

Beyond standard EF measurement (2D biplane Simpson’s or 3D), echo contributes specific, named signs relevant to cardiac resynchronization therapy candidacy and response:

• Apical rocking — a visually recognizable to-and-fro motion of the LV apex from dyssynchronous contraction.
• Septal flash — an early systolic septal motion abnormality, best appreciated on a longitudinal view, from early activation of the septum relative to the lateral wall.
• Quantitative dyssynchrony assessment (interventricular, atrioventricular, and intraventricular timing) has real conceptual appeal but genuinely limited validated technique — current guidance is honest that further evidence is still needed before any single quantitative method can be relied upon on its own.
• Stress echocardiography has a role in assessing both myocardial viability and dyssynchrony in selected patients being considered for device therapy, and echo also contributes to CRT optimization after implantation.

Stress Echocardiography in DCM

Used selectively rather than routinely — exercise, dobutamine, and dipyridamole protocols have each been studied, primarily for assessing contractile reserve, viability, and the hemodynamic response relevant to device therapy and prognosis, alongside the dyssynchrony assessment described above.

Prognostic Indicators

Several echocardiographic findings carry independent prognostic weight, worth stating explicitly in a report rather than only as isolated measurements:

• EF under 30% is associated with a meaningfully higher risk of heart failure progression and sudden cardiac death.
• Reduced global longitudinal strain correlates with adverse outcomes, often detecting risk before EF itself has fallen.
• A restrictive or pseudonormalized diastolic filling pattern, particularly with E/e′ above 15, is an independent marker of poor prognosis.
• Moderate or greater secondary mitral regurgitation worsens prognosis beyond the degree of LV dysfunction alone.
• Coexisting RV dysfunction adds independent prognostic weight to LV measures.
• Pulmonary hypertension indicates more advanced disease and a worse prognosis.
• Left atrial enlargement, reflecting the duration and severity of chronically elevated filling pressure, is itself associated with worse outcomes.

Follow-Up and Monitoring

Serial echocardiography tracks the trajectory of ventricular size, function, and the associated findings above — genuinely important given how much DCM’s course can vary with treatment response, since a meaningful minority of patients show substantial recovery of function with guideline-directed medical therapy, while others progress despite it. Reassessing LVEF is also how cardiac resynchronization therapy candidacy and response are judged over time, alongside the dyssynchrony signs described above.

Clinical Importance

DCM is the cardiomyopathy phenotype most likely to be encountered as a heart-failure “default” diagnosis, which is exactly why the differential-diagnosis discipline matters so much here: confirming genuinely global rather than regional dysfunction, actively excluding valvular, restrictive, and pericardial mimics, and recognizing the small set of findings that do point toward a specific cause — rather than accepting “DCM, etiology unclear” as the end of the diagnostic process — is what separates a complete echocardiographic evaluation from a merely adequate one.